Amendment to Framework Decision 2004/757/JHA
Article 1
Open ↗The following is added to the list in the Annex to Framework Decision 2004/757/JHA: ‘13. N -phenyl- N -[1-(2-phenylethyl)piperidin-4-yl]furan-2-carboxamide (furanylfentanyl), as referred to in Council Implementing Decision (EU) 2017/2170 ( *1 ) . 14. N -(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1 H -indazole-3-carboxamide (ADB-CHMINACA), as referred to in Council Implementing Decision (EU) 2018/747 ( *2 ) . 15. 1-(4-cyanobutyl)- N -(2-phenylpropan-2-yl)-1 H -indazole-3-carboxamide (CUMYL-4CN-BINACA), as referred to in Council Implementing Decision (EU) 2018/748 ( *3 ) . 16. N -phenyl- N -[1-(2-phenylethyl)piperidin-4-yl]cyclopropanecarboxamide (cyclopropylfentanyl) and 2-methoxy- N -phenyl- N -[1-(2-phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl), as referred to in Council Implementing Decision (EU) 2018/1463 ( *4 ) .